首页/数据集/Molecular Glue Degraders of HuR to Treat BRAF-Mutant Colorectal Cancer

Molecular Glue Degraders of HuR to Treat BRAF-Mutant Colorectal Cancer

Name: Molecular Glue Degraders of HuR to Treat BRAF-Mutant Colorectal Cancer
Creator: ShanghaiTech University
Published: 2026-04-19T22:35:52+08:00

integrated proteome resources2026-05-02 收录

癌症靶向治疗

分子胶降解剂

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0016696000 数据链接链接失效反馈

官方服务：

资源简介：

Molecular Glue Degraders of HuR to Treat BRAF-Mutant Colorectal Cancer

应用场景：

提供机构：

ShanghaiTech University

创建时间：

2026-04-19

相关数据集

Affinity and energy docking results.

分子对接

癌症靶向治疗

Objective We investigated the potential molecular mechanisms of Synechococcus sp. XM-24 affect gastric cancer (GC) development. Furthermore, this study aimed to provide a theoretical basis for develop

NIAID Data Ecosystem20

Table_5_Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer.xlsx

双特异性抗体

癌症靶向治疗

The ErbB family of receptor tyrosine kinases is a primary target for small molecules and antibodies for pancreatic cancer treatment. Nonetheless, the current treatments for this tumor are not optimal

NIAID Data Ecosystem00

Structural Insight into Inhibitor of Apoptosis Proteins Recognition by a Potent Divalent Smac-Mimetic

癌症靶向治疗

结构生物学

Genetic alterations enhancing cell survival and suppressing apoptosis are hallmarks of cancer that significantly reduce the efficacy of chemotherapy or radiotherapy. The Inhibitor of Apoptosis Protein

Figshare2016-01-19 更新00

FateMap Paper datasets #1 (Goyal et al., 2021, Biorxiv)

癌症靶向治疗

药物响应机制

Datasets from: https://www.biorxiv.org/content/10.1101/2021.12.08.471833v1.full FM01: BRAF-mutant melanoma WM989 treated with vemurafenib (provided here) FM02: BRAF-mutant melanoma WM989 treated with

Figshare2023-05-11 更新00

Discovery and Characterization of Small Molecule Inhibitors of SWI/SNF ATPase Activity in BRG1/SMARCA4-Deficient Non-Small Cell Lung Cancers

癌症靶向治疗

表观遗传调控

Members of the ATP-dependent SWI/SNF chromatin remodeling complexes are among the most frequently mutated genes across various cancers informing critical roles of their dysregulation towards the malig

NIAID Data Ecosystem00